nsc 3852 has been researched along with sybr green i in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Lindsay, DS; Mitchell, SM; Nagarkatti, R; Rathore, D; Rosypal, AC; Seibert, CW; Strobl, JS | 1 |
1 other study(ies) available for nsc 3852 and sybr green i
Article | Year |
---|---|
Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
Topics: Animals; Antineoplastic Agents; Antioxidants; Antiprotozoal Agents; Benzothiazoles; Cell Line; Cells, Cultured; Diamines; Erythrocytes; Fibroblasts; Fluorescent Dyes; Humans; Hydroxyquinolines; Nitric Oxide; Nitroso Compounds; Organic Chemicals; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Reactive Oxygen Species; Toxoplasma | 2009 |